openPR Logo
Press release

Novel Drug Reconstitution Systems Market, 2021-2030

01-10-2022 08:33 AM CET | Health & Medicine

Press release from: Roots Analysis

In 2018, seven out of ten top-selling prescription medicines were biologics. The liquid formulations of biologics are not much stable and tend to lose efficacy with time due to the changes in their pharmacokinetic and pharmacodynamic properties. Therefore, lyophilization of such drugs is essential before their storage. Around 50% of the biologics intended for parenteral administration are available in lyophilized form, which require reconstitution before administration.
To Request for sample -

The traditional methods of drug reconstitution involve manual extraction and transfer of diluent for mixing the drug. As such, these methods are complex and associated with several concerns including, large number of steps, multiple containers, and medications errors, which made reconstitution of various lyophilized drugs and vaccines a challenge in commercialization of these drugs. This has led to the development of novel drug reconstitution systems, which enable simple and effective way of reconstitution and administration of lyophilized products.

Reconstitution is the process, which involves mixing of dried therapeutic with a sterile diluent to reformulate it into liquid form before administration. It is multi-step process that involves the manual extraction and transfer of diluent from first vial to the second vial, containing the lyophilized product using syringe and transfer needle. After transferring, the contents are mixed until the final mixture is fully reconstituted. The process is usually performed by a trained healthcare provider or caregivers and requires the use of vial adaptors, vial-to-vial systems and advanced dual chamber reconstitution systems.

VDAs target the endothelial cells of tumor blood vessel that are involved in processes like migration, adhesion, cohesion, and proliferation which further alternates the shape of the endothelial cells, break the cell-to-cell junctions, thereby, leading to loss of cohesion and ultimately resulting in ischemia and tumor necrosis. They have shown greatest effect in combination with conventional chemotherapy or other modes of treatment that selectively target and attack cancer cells. Presently, there are multiple small molecule VDAs, which have been/are being developed for the treatment of a variety of oncological conditions, including colorectal cancer, glioblastoma, hepatocellular carcinoma, lung cancer, melanoma and ovarian cancer.
To order this detailed 180+ page report, please visit this -

The reconstitution system offers multiple benefits to patients as well as biopharmaceutical and pharmaceutical companies, enabling them to store the lyophilized therapeutics in the container closure system.

The shortage of easy-to-use drug reconstitution delivery systems has limited the market opportunities in the past. However, with the introduction of novel drug reconstitution systems, delivery of lyophilized drugs has become convenient. Such systems provide better treatment options to patients, save time and labor of caregivers. Owing to the various benefits offered by novel drug reconstitution systems, and the growing pipeline of biologics and lyophilized formulations, adoption of novel drug reconstitution systems is anticipated to increase, and this segment of the pharmaceutical industry is likely to witness significant developments in the coming years.
Other Recent Offerings
1. Global Autoinjectors Market (3rd Edition), 2020-2030
2. Prefilled Syringes Market (5th Edition), 2020-2030
3. Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030
4. Large Volume Wearable Injectors Market (4th Edition), 2018-2030

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at

Contact Details
Ben Johnson
+1 (415) 800 3415

Roots Analysis

30.65, A 430, Bestech Business Towers,, Sector 66, Sahibzada Ajit Singh Nagar, Punjab 160066

We specialise in analysing areas which have lacked quality research so far or require more focussed understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Novel Drug Reconstitution Systems Market, 2021-2030 here

News-ID: 2521595 • Views: 144

More Releases from Roots Analysis

Squamous Non-small Cell Lung Cancer Market, 2021-2031 by Roots Analysis
Advances in molecular biology and tumor immunology have enabled the development of NSCLC targeting therapies, which have the ability to impede cancer growth by altering chemical reactions associated with oncogenic driver mutations Roots Analysis has announced the addition of “Squamous Non-small Cell Lung Cancer Market, 2021-2031” report to its list of offerings. Success of approved squamous non-small cell lung cancer therapies, such as Keytruda®, Opdivo® and Portrazza®, has resulted in a
The TIL-based therapies market is projected to be worth over USD 4.3 billion, by …
Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings. Given the frequently reported inadequacies of conventional cancer therapies and the growing need for personalized medicine, there is a marked surge
The novel ocular drug delivery devices market is projected to grow at a CAGR of …
The delivery of drugs in ocular regions is known to be considerably more challenging; several pharmaceutical companies are actively undertaking initiatives to identify novel approaches for safe and efficient administration of therapies to eyes Roots Analysis has announced the addition of the “Novel Ocular Drug Delivery Devices Market, 2021 – 2030” report to its list of offerings. Over the years, a number of companies have developed several novel and advanced drug
The progressive supranuclear palsy (PSP) therapies market, is anticipated to gro …
The exact cause of this rare disorder, which affects 5-17 in 100,000 people, is unknown; however, a complex interplay between different risk factors, including age, genetics and environment, is likely to contribute to the onset of this rare tauopathy London Roots Analysis has announced the addition of “Progressive Supranuclear Palsy Therapies Market, 2021-2030” report to its list of offerings. Presently, there is no cure for PSP and the effectiveness of prescribed generic

All 5 Releases

More Releases for Edition

Updated Edition Reports Global Drillship Market Report: 2014 Edition
"The Report Global Drillship Market Report: 2014 Edition provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" A drillship is a merchant vessel designed for use in exploratory offshore drilling of new oil and gas wells or for scientific drilling purposes. In most recent years, the vessels are used in deepwater and ultra-deepwater applications, equipped with the latest and most advanced dynamic positioning
Tweaked Automotive ‘Spectre Edition’
Tweaked Automotive announces its most recent special edition release, the Spectre Edition Land Rover Defender. The idea of executing a special Land Rover Defender build was circulating around the Tweaked Automotive design department for some time. The fact Land Rover ceased production of these much loved four wheel drives that have been around since 1948 prompted Tweaked Automotive to get stated as a matter of urgency. Hand in hand the 007TM
02-08-2013 | Arts & Culture
Anniversary Edition: Réne Leibowitz
RENÉ LEIBOWITZ COMPOSITEUR 1913 - 1972 SCHOLA HEIDELBERG, ensemble aisthesis, Walter Nußbaum, conductor Ivry Gitlis, violin - Symphony Orchestra of the NDR, René Leibowitz, conductor CD 1: A co-production with HR2 (Hessischer Rundfunk) As a conductor, author and teacher, he is a legend - but as a composer he has remained a phantom: in time for René Leibowitz' 100th birthday on Febru a ry 17, 2013, Divox releases a sumptuous double album in
QUADROtech announces EVnearSync cloud edition
The Swiss software company QUADROtech announced today that it will be releasing a cloud edition of QUADROtech EVnearSync soon. EVnearSync allows customers who work with Symantec Enterprise Vault to have the benefit of zero data loss and higher availability in disaster cases. Furthermore, normal backups of the archiving storage are not needed anymore thus lowering operational costs tremendously. The cloud version in its smallest edition with 10 TB of storage space will
Tideway Launches Foundation Community Edition
NEW YORK and LONDON: November 17, 2008 – Tideway, one of the fastest growing providers of IT automation software, today launched the beta version of Tideway Foundation™ Community Edition, a free, downloadable version of Tideway’s award-winning automated discovery and application dependency mapping software, Tideway Foundation. Users can now deploy Tideway Foundation for free in their own IT environment to accelerate cost-saving initiatives like server consolidation, virtualization, and data center migrations. Foundation
TheDevShop Releases dbQwikSite Developer Edition
TheDevShop Ltd today announced the release of dbQwikSite Developer Edition, a special edition of its popular website building software targeting the advanced needs of web developers and web designers. What is dbQwikSite? dbQwikSite is a web code generator producing dynamic web pages that interact with an online database. dbQwikSite’s advanced code generation creates all the scripts for web pages to display, search and edit online database content. Using dbQwikSite